multiple sclerosis

lightbulb explosion art
CRO

Sanofi will deploy new AI tool in late-stage MS trials

Sanofi, Formation Bio and OpenAI have jointly designed an AI-powered tool that will be rolled out in the former's phase 3 multiple sclerosis trials.
Gabrielle Masson Nov 13, 2024 7:40am
failure crash no fail rocket cancelled end

Sanofi flunks MS study, dealing another blow to Denali pact

Oct 11, 2024 5:56am
positive negative up down good bad mixed

Sanofi lifts lid on data behind tolebrutinib’s mixed MS studies

Sep 20, 2024 7:07am
plan B fail reroute road path trail miss

Sanofi's tolebrutinib fails 2 of 3 late-stage MS trials

Sep 2, 2024 1:00am
brain amyloid alzheimers strings detailed web complicated thought

Siemens Healthineers nets CE Mark for MS relapse risk blood test

Jun 17, 2024 11:30am
IPO initial public offering Wall Street

Contineum lowers expectations for $110M IPO

Apr 5, 2024 7:00am